Short Interest in Idorsia Ltd (OTCMKTS:IDRSF) Decreases By 20.0%

Idorsia Ltd (OTCMKTS:IDRSF) was the target of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 7,229,000 shares, a decrease of 20.0% from the November 30th total of 9,037,200 shares. Based on an average daily volume of 10,700 shares, the days-to-cover ratio is currently 675.6 days.

Idorsia Stock Up 21.4 %

Shares of IDRSF stock traded up $0.15 on Tuesday, hitting $0.85. 12,700 shares of the stock traded hands, compared to its average volume of 3,559. Idorsia has a 52 week low of $0.70 and a 52 week high of $2.88. The firm has a 50 day simple moving average of $1.12 and a two-hundred day simple moving average of $1.99.

Idorsia Company Profile

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.